Progyny logo

ProgynyNASDAQ: PGNY

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 October 2019

Next earnings report:

12 November 2024

Last dividends:

N/A

Next dividends:

N/A
$1.37 B
-77%vs. 3y high
76%vs. sector
-81%vs. 3y high
45%vs. sector
-88%vs. 3y high
70%vs. sector
-90%vs. 3y high
26%vs. sector

Price

after hours | 56 min ago
$15.15+$0.27(+1.81%)

Dividend

No data over the past 3 years
$304.09 M$296.88 M
$304.09 M$16.48 M

Analysts recommendations

Institutional Ownership

PGNY Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
accesswire.com04 November 2024 Sentiment: -

NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
prnewswire.com02 November 2024 Sentiment: NEGATIVE

NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
accesswire.com31 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report
globenewswire.com29 October 2024 Sentiment: POSITIVE

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended September 30, 2024 after the close of the market on Tuesday, November 12, 2024.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
accesswire.com27 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
prnewswire.com25 October 2024 Sentiment: NEGATIVE

NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman
globenewswire.com21 October 2024 Sentiment: NEGATIVE

SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
accesswire.com19 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
prnewswire.com17 October 2024 Sentiment: NEGATIVE

NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Progyny (PGNY) Crashes After Losing Significant Client - Hagens Berman
accesswire.com16 October 2024 Sentiment: NEGATIVE

PGNY Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCICSO, CA / ACCESSWIRE / October 16, 2024 / Hagens Berman urges Progyny, Inc. (NASDAQ:PGNY) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys.

What type of business is Progyny?

Progyny, Inc. is an American company specializing in managing benefits in the field of reproductive health. Previously known as Auxogyn, Inc., the company changed its name to Progyny, Inc. in 2015. Progyny, Inc. was registered in 2008, with its headquarters located in New York, New York. The company offers the Smart Cycle treatment package, which includes all necessary diagnostic tests and access to the latest technologies (such as preimplantation genetic testing in the case of IVF treatment). Smart Cycle provides 17 different procedure packages that can be used independently or in combination, depending on the participant's needs. The company also offers Progyny Rx - a comprehensive pharmacy benefit solution that provides participants with access to medications needed during their treatment.

What sector is Progyny in?

Progyny is in the Healthcare sector

What industry is Progyny in?

Progyny is in the Health Information Services industry

What country is Progyny from?

Progyny is headquartered in United States

When did Progyny go public?

Progyny initial public offering (IPO) was on 25 October 2019

What is Progyny website?

https://www.progyny.com

Is Progyny in the S&P 500?

No, Progyny is not included in the S&P 500 index

Is Progyny in the NASDAQ 100?

No, Progyny is not included in the NASDAQ 100 index

Is Progyny in the Dow Jones?

No, Progyny is not included in the Dow Jones index

When was Progyny the previous earnings report?

No data

When does Progyny earnings report?

The next expected earnings date for Progyny is 12 November 2024